Presage Biosciences Announces New Pharma Partnership to Evaluate Novel Immuno-Oncology Drug Combinations with CIVO® TechnologyPRNewsWire • 11/30/23
Investors Heavily Search AstraZeneca PLC (AZN): Here is What You Need to KnowZacks Investment Research • 11/24/23
Eli Lilly and Novo Nordisk Are Big Names in Weight Loss, but Investors Shouldn't Count Out This Healthcare GiantThe Motley Fool • 11/22/23
U.S. FDA Approves FoundationOne®CDx as a Companion Diagnostic for AstraZeneca's Truqap™ (capivasertib) in combination with Faslodex® (fulvestrant) to Identify Patients with HR-Positive, HER2-Negative Advanced Breast CancerBusiness Wire • 11/20/23
AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomesBusiness Wire • 11/20/23
Third Success from Astex Drug Discovery Pharma Collaboration and Licence Agreements as AstraZeneca Receives US Marketing Approval for Cancer Drug Truqap (capivasertib)GlobeNewsWire • 11/20/23
AstraZeneca Is Trying to Make an Ozempic Competitor (Again), but Don't Rush to Buy the StockThe Motley Fool • 11/17/23
CDC expedites release of more doses of infant RSV drug from Sanofi, AstraZeneca amid shortageCNBC • 11/17/23